Prevalence of various psychotic disorders among patients with type 2 diabetes: Real-world evidence from Shanghai, China
Aims: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that significantly impacts psychotic health, leading to increased incidence and mortality. We aim to explore the status of patients with T2DM and the issue of comorbid psychotic disorders. Methods: Our study estimated the characte...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Diabetes Epidemiology and Management |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666970625000083 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849728072812593152 |
|---|---|
| author | Yunxi Ji Ping He Yingxia Zhou Huayan Yao Yanbin Xue Renjie Jing Tingyu Zhang Wen Sun Ping Lu Bin Cui Weiqing Wang |
| author_facet | Yunxi Ji Ping He Yingxia Zhou Huayan Yao Yanbin Xue Renjie Jing Tingyu Zhang Wen Sun Ping Lu Bin Cui Weiqing Wang |
| author_sort | Yunxi Ji |
| collection | DOAJ |
| description | Aims: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that significantly impacts psychotic health, leading to increased incidence and mortality. We aim to explore the status of patients with T2DM and the issue of comorbid psychotic disorders. Methods: Our study estimated the characteristics of 836,120 patients with T2DM from 2019 to 2023 based on electronic health records from the Shanghai Link Database (SHLD). We calculated the prevalence of the four major psychotic disorders in patients with T2DM, including depression, anxiety, dementia, and schizophrenia. The data was also stratified by age, sex, and other factors. Additionally, the association between diabetes complications and various psychotic disorders was investigated. Results: We observed that the age group of 55-80 counted for about 68.15% of the total population with T2DM. There were more male patients with T2DM than females, but females exhibited a higher overall prevalence of psychotic disorders compared to males. For patients with T2DM, anxiety had the highest prevalence (3.97%), followed by depression (2.33%), dementia (2.04%), and schizophrenia (0.16%). There was a significant relationship between psychotic disorders and various diabetes complications. Conclusions: The high prevalence of psychotic disorders among patients with T2DM highlights the importance of considering the impact of their comorbid psychotic illnesses when treating T2DM. Developing high-quality diabetes healthcare and implementing targeted treatment and management plans are essential in addressing these issues. |
| format | Article |
| id | doaj-art-dda197d62a874b3db9f8fe0dab21d573 |
| institution | DOAJ |
| issn | 2666-9706 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Diabetes Epidemiology and Management |
| spelling | doaj-art-dda197d62a874b3db9f8fe0dab21d5732025-08-20T03:09:39ZengElsevierDiabetes Epidemiology and Management2666-97062025-04-011810025910.1016/j.deman.2025.100259Prevalence of various psychotic disorders among patients with type 2 diabetes: Real-world evidence from Shanghai, ChinaYunxi Ji0Ping He1Yingxia Zhou2Huayan Yao3Yanbin Xue4Renjie Jing5Tingyu Zhang6Wen Sun7Ping Lu8Bin Cui9Weiqing Wang10Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaLink Healthcare Engineering and Information Department, Shanghai Hospital Development Center, Shanghai, ChinaDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaComputer Net Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaComputer Net Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaWonders Information Co. Ltd., Shanghai, ChinaWonders Information Co. Ltd., Shanghai, ChinaDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Corresponding authors at: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 573 Xujiahui Road, Shanghai, 200025 China.Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Corresponding authors at: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 573 Xujiahui Road, Shanghai, 200025 China.Aims: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that significantly impacts psychotic health, leading to increased incidence and mortality. We aim to explore the status of patients with T2DM and the issue of comorbid psychotic disorders. Methods: Our study estimated the characteristics of 836,120 patients with T2DM from 2019 to 2023 based on electronic health records from the Shanghai Link Database (SHLD). We calculated the prevalence of the four major psychotic disorders in patients with T2DM, including depression, anxiety, dementia, and schizophrenia. The data was also stratified by age, sex, and other factors. Additionally, the association between diabetes complications and various psychotic disorders was investigated. Results: We observed that the age group of 55-80 counted for about 68.15% of the total population with T2DM. There were more male patients with T2DM than females, but females exhibited a higher overall prevalence of psychotic disorders compared to males. For patients with T2DM, anxiety had the highest prevalence (3.97%), followed by depression (2.33%), dementia (2.04%), and schizophrenia (0.16%). There was a significant relationship between psychotic disorders and various diabetes complications. Conclusions: The high prevalence of psychotic disorders among patients with T2DM highlights the importance of considering the impact of their comorbid psychotic illnesses when treating T2DM. Developing high-quality diabetes healthcare and implementing targeted treatment and management plans are essential in addressing these issues.http://www.sciencedirect.com/science/article/pii/S2666970625000083Type 2 diabetes mellitusPsychotic disordersPrevalencePrimary careGender differences |
| spellingShingle | Yunxi Ji Ping He Yingxia Zhou Huayan Yao Yanbin Xue Renjie Jing Tingyu Zhang Wen Sun Ping Lu Bin Cui Weiqing Wang Prevalence of various psychotic disorders among patients with type 2 diabetes: Real-world evidence from Shanghai, China Diabetes Epidemiology and Management Type 2 diabetes mellitus Psychotic disorders Prevalence Primary care Gender differences |
| title | Prevalence of various psychotic disorders among patients with type 2 diabetes: Real-world evidence from Shanghai, China |
| title_full | Prevalence of various psychotic disorders among patients with type 2 diabetes: Real-world evidence from Shanghai, China |
| title_fullStr | Prevalence of various psychotic disorders among patients with type 2 diabetes: Real-world evidence from Shanghai, China |
| title_full_unstemmed | Prevalence of various psychotic disorders among patients with type 2 diabetes: Real-world evidence from Shanghai, China |
| title_short | Prevalence of various psychotic disorders among patients with type 2 diabetes: Real-world evidence from Shanghai, China |
| title_sort | prevalence of various psychotic disorders among patients with type 2 diabetes real world evidence from shanghai china |
| topic | Type 2 diabetes mellitus Psychotic disorders Prevalence Primary care Gender differences |
| url | http://www.sciencedirect.com/science/article/pii/S2666970625000083 |
| work_keys_str_mv | AT yunxiji prevalenceofvariouspsychoticdisordersamongpatientswithtype2diabetesrealworldevidencefromshanghaichina AT pinghe prevalenceofvariouspsychoticdisordersamongpatientswithtype2diabetesrealworldevidencefromshanghaichina AT yingxiazhou prevalenceofvariouspsychoticdisordersamongpatientswithtype2diabetesrealworldevidencefromshanghaichina AT huayanyao prevalenceofvariouspsychoticdisordersamongpatientswithtype2diabetesrealworldevidencefromshanghaichina AT yanbinxue prevalenceofvariouspsychoticdisordersamongpatientswithtype2diabetesrealworldevidencefromshanghaichina AT renjiejing prevalenceofvariouspsychoticdisordersamongpatientswithtype2diabetesrealworldevidencefromshanghaichina AT tingyuzhang prevalenceofvariouspsychoticdisordersamongpatientswithtype2diabetesrealworldevidencefromshanghaichina AT wensun prevalenceofvariouspsychoticdisordersamongpatientswithtype2diabetesrealworldevidencefromshanghaichina AT pinglu prevalenceofvariouspsychoticdisordersamongpatientswithtype2diabetesrealworldevidencefromshanghaichina AT bincui prevalenceofvariouspsychoticdisordersamongpatientswithtype2diabetesrealworldevidencefromshanghaichina AT weiqingwang prevalenceofvariouspsychoticdisordersamongpatientswithtype2diabetesrealworldevidencefromshanghaichina |